FDA Approves New DVT Treatment

The FDA has approved the use of the anti-clotting drug apixaban (Eliquis) to treat deep vein thrombosis (DVT) and pulmonary embolism (PE).

Apixaban is also now approved to lower the risk of DVT and PE returning in people who’ve already had one.

The FDA posted a copy of an Aug. 19 letter to drugmaker Bristol-Myers, announcing its decision. Apixaban was already approved for use in lowering the risks of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem and to prevent DVT and PE in people who’ve had hip- or knee-replacement surgery.

FDA Approves New DVT Treatment

Last month the European Commission granted a similar extension of apixaban in countries where drug policies are covered by the European Medicines Agency.

Other blood thinners, including rivaroxaban (Xarelto)and dabigatran (Pradaxa), are also FDA-approved for the treatment of DVT and PE and the prevention of DVT or PE’s return.

Source: web md


E-Cigarettes Should be a Last Resort, Heart Doctors Say

E-cigarettes should be outlawed for minors and only be used as a last resort to quit smoking, the American Heart Association says in a new policy statement. And the Food and Drug Administration should hurry up and regulate them, the group says. “Over the last 50 years, 20 million Americans died because of tobacco. We are fiercely committed to preventing the tobacco industry from addicting another generation of smokers,” Nancy Brown, CEO of the American Heart Association, says in a statement. “Recent studies raise concerns that e-cigarettes may be a gateway to traditional tobacco products for the nation’s youth, and could renormalize smoking in our society.”

E-Cigarettes Should be a Last Resort, Heart Doctors Say

The Food and Drug Administration says it plans to regulate e-cigarettes, along with cigars and other tobacco products. Many “vapers” who use e-cigarettes say regulation will damage a product that’s a far safer substitute for cigarettes. The Heart Association disagrees. “In the years since the FDA first announced it would assert its authority over e-cigarettes, the market for these products has grown dramatically,” Brown said. “We fear that any additional delay of these new regulations will have real, continuing public health consequences.”

Source: nbc news


Double vaccines ‘could hasten the end of polio’

Using both types of polio vaccine could speed up efforts to free the world of the disease, research suggests.

The oral vaccine is leading the fight to eradicate polio, but trials in India show an additional injection of inactivated virus boosts immunity.

The World Health Organization said the findings, published in the journal Science, were “truly historic”.

The disease, which is spread through contaminated faeces, can cause paralysis and even death.

Double vaccines 'could hasten the end of polio'

Fighting polio has been one of the biggest success stories in global health.

In 1988, there were 350,000 cases of polio in more than 125 countries.

The disease is now widespread in just three countries – Nigeria, Afghanistan and Pakistan – and cases have fallen by more than 99%.

Vaccines
Two drops of the oral vaccine, which contains a weakened polio virus, is the preferred tool in eradication efforts because it is cheap and gives resistance in the digestive tract to lower transmission of the virus.

The injected vaccine works largely in the bloodstream.

“But the oral vaccine is less effective in exactly those places we’d like it to work,” one of the researchers, Prof Nicholas Grassly, of Imperial College London, told the BBC.

It is thought other infections may interfere with the vaccine.

The solution has been multiple vaccination. As part of India’s successful eradication campaign, some children received 30 doses by the age of five.

Source: bbc news


British scientists create first complete working organ from cells

British scientists have built a complete and functional organ in a living animal for the first time

British scientists have produced the first working organ by reprogramming cells in a step towards the ‘Holy Grail’ of being able to grow replacement organs for humans.

In future the technique, so far only tested on mice, could be used to provide replacement organs for people with weakened immune systems and eventually lead on the production of more complex organs for transplant. The technique could be used in humans in ten years.
Scientiststs created a working thymus, a vital immune system “nerve centre” located near the heart, with connective tissue cells from a mouse embryo which were converted into a completely different cell strain by flipping a genetic “switch” in their DNA.

The resulting cells grew spontaneously into the whole organ when injected into the mouse with other similar cells.

British scientists have built a complete and functional organ in a living animal for the first time

Professor Clare Blackburn, from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh, who led the team of scientists, said: “The ability to grow replacement organs from cells in the lab is one of the ‘holy grails’ in regenerative medicine. But the size and complexity of lab-grown organs has so far been limited.

“By directly reprogramming cells we’ve managed to produce an artificial cell type that, when transplanted, can form a fully organised and functional organ. This is an important first step towards the goal of generating a clinically useful artificial thymus in the lab.”

The thymus is the central hub of the immune system sending out infection fighting T-cells.

People with a defective thymus lack functioning T-cells and are highly vulnerable to infections. This is especially hazardous for bone marrow transplant patients, who need a working thymus to rebuild their immune systems after surgery.

Around one in 4,000 babies born each year in the UK have a malfunctioning or completely absent thymus, due to rare conditions such as DiGeorge syndrome.

Thymus disorders can be treated with infusions of extra immune cells or transplantation of a new organ soon after birth. However, such approaches are severely limited by a lack of donors and tissue rejection.

The new research, published in the journal Nature Cell Biology, raises the possibility of creating a whole new functioning thymus using cells manufactured in the laboratory.
While fragments of organs, including hearts, livers and even brains, have been grown from stem cells, no one before has succeeded in producing a fully intact organ from cells created outside the body.

Dr Rob Buckle, head of regenerative medicine at the MRC, said: “Growing ‘replacement parts’ for damaged tissue could remove the need to transplant whole organs from one person to another, which has many drawbacks – not least a critical lack of donors.

“This research is an exciting early step towards that goal, and a convincing demonstration of the potential power of direct reprogramming technology, by which once cell type is converted to another. However, much more work will be needed before this process can be reproduced in the lab environment, and in a safe and tightly controlled way suitable for use in humans.”

Chris Mason, Professor of Regenerative Medicine at University College London, said: “Using living cells as therapies has the big advantage in that the functionality of cells is many orders of magnitude greater than that of conventional drugs. Nowhere is this level of functionality more needed than in curing disorders of the immune system.

“The time and resources required to turn this mouse proof-of-concept study into a safe and effective routine therapy for patients will be very significant – 10 years and tens of millions of pounds at a bare minimum. Even the starting point, the underpinning science, is far from complete: for example, not all the cells that are required can yet be made in the lab. However, the … data strongly support the urgent need for more scientists, together with engineers and clinicians, to now get involved in order to evaluate and develop this new technology.”

Dr Paolo de Coppi, consultant paediatric surgeon at Great Ormond Street Hospital and head of Stem Cells and Regenerative Medicine at the Institute of Child Health, London, said: “Research such as this demonstrates that organ engineering could, in the future, be a substitute for transplantation, overcoming problems such as organ donor shortages and bypassing the need for immunosuppressive therapy.

“It remains to be seen whether, in the long term, cells generated using direct reprogramming will be able to maintain their specialised form and avoid problems such as tumour formation.”

Source: The telegraph


Nigeria: Bodies of Ebola Victims Cremated in Lagos

Bodies of the four Nigerians, who died of Ebola Virus Disease, EVD, have been cremated in line with World Health Organisation, WHO, requirements for disposal of such corpses. The body of the index (first) case, Patrick Sawyer was the first to be cremated on July 25, 2014.

The decision to cremate the bodies, it was gathered, may not be unconnected with the deadly nature of the Ebola Virus which is known to be easily transmissible from human to human during handling of corpses of victims.

A health official at the Emergency Operation Centre, EOC, of the Mainland Hospital, Lagos, who confirmed the development, said the Lagos State Government in following strict guidelines for disposal of the bodies, authorised cremation of all the bodies.

Bodies of Ebola Victims Cremated in Lagos

The official who pleaded anonymity said the decision to cremate all bodies was to ensure appropriate containment measures and guarantee proper handling of the bodies.

“All the bodies of those who died of Ebola from this centre have been cremated. None was allowed to undergo traditional burial because extreme care is being taken to prevent further infections,” the official noted.

The WHO in recommending that people who die from Ebola should be promptly and safely buried, notes that cremation, which is the application of high temperature to reduce bodies to basic chemical components (ashes), is ideal for safe disposal of bodies of such persons in order to minimise further transmission.

In a statement weekend, the ECOWAS Commission stated that the remains of its Protocol Assistant at the Lagos Liaison Office, Mr. Salihu Abdulqudir Jatto, who succumbed to the Ebola Virus Disease, EVD, on August 12, 2014, had been laid to rest in a private ceremony in Ikorodu, Lagos state.

The statement said a delegation from the Commission had earlier paid a condolence visit to the deceased’s widow and other members of his family.

Jatto was among persons that assisted the American-Liberian Mr. Patrick Sawyer, and contracted the disease from the late Sawyer who took ill on arrival in Nigeria on July 20, 2014 on his way to a regional conference in Calabar, and later died in a Lagos hospital of the EVD.

The statement noted that prior to the burial last Friday, a special prayer service in honour of the deceased was held at the Commission’s Abuja Headquarters. The activity was presided over by Vice President of the Commission Dr. Toga Gayewea McIntosh who represented the President of the Commission, Kadré Desire Ouédraogo.

Glowing tributes were paid in memory of Jatto, who was variously described as a diligent, passionate, humble and hardworking staff, who died a hero in the course of duty.

Leading the other mourning colleagues in the outpouring of grief, McIntosh described Jatto as “a sharp, young, aggressive goal-getter and a personal friend.

“We are all touched by his death, which is both a personal and collectively loss,” McIntosh said, praying for the repose of Jatto’s soul.

Head of Protocol at the Commission, Mr. Steve Onwuka, narrated examples of Jatto’s unique “unassuming, humble and infectious” character and recalled that Jatto died at a time the world attention was focused on the region, albeit for the Ebola health emergency.

Others who spoke at the occasion, include Mr. Hyacinth Okwu, of the Finance Directorate; Mr. Franck Afanyiakossou, and Mr. Joshua Iyamu, a member of the Staff Association, all acknowledged Jatto’s legacy of service and exemplary character.

They appealed for improvement of the staff welfare and asked for special care of Jatto’s wife and children given the circumstance of his death.

Earlier, Mr. Saihou Njie, of the Human Resources Directorate said the ceremony was part of the traditional gestures of honour to a departed colleague.

Source: all africa


Aspirin not only prevents pain but also promotes recovery

According to a new study published online in PNAS, aspirin has a dual role in acting on pain. Not only does it prevent inflammation and pain but also hastens the end of inflammation.

According to the study, the drug kills cyclooxygenase, thus preventing production of the prostaglandins that cause inflammation and pain and also prompts the enzyme to generate another compound that hastens the end of inflammation, returning the affected cells to homeostatic health.  Edward A. Dennis said that aspirin causes the cyclooxygenase to make a small amount of a related product called 15-HETE and during infection and inflammation, the 15-HETE can be converted by a second enzyme into lipoxin, which is known to help reverse inflammation and cause its resolution – a good thing.

Aspirin not only prevents pain but also promotes recovery

The researchers found that macrophages contain the biochemical tools to not just initiate inflammation, a natural part of the immune response, but also to promote recovery from inflammation by releasing 15-HETE and converting it into lipoxin as the inflammation progresses.

Here are some other amazing facts about aspirin you should know:

1. It is the most widely used drug: Aspirin, chemically known as acetylsalicylic acid, is truly a boon to the medical world. This wonder drug was first brought to the pharmaceutical industry in the year 1899, when it was introduced for the treatment of rheumatic fever and gout. Since then it is the most extensively used therapeutic chemical and is still the first choice of treatment for minor pains and fever.

2. Most people take the drug without even realising it:  Most people don’t realise that they are actually taking an aspirin because it is not only found as a single ingredient but is also present in combination with other prescribed and over-the-counter drugs. Most drugs containing aspirin have it labelled as ASA or spelled out as acetylsalicylic acid.

3. It is used for relieving more than 50 symptoms: The role of aspirin in treatment of various conditions has been studied. Aspirin is most commonly used for symptoms like heartburn, fever, arthritis, stomach ache, sleep disorders, migraine headaches and symptoms of common cold.

4. Aspirin could benefit 11 different cancers: Aspirin has a significant ability to inhibit the growth of cancer cells. A new aspirin drug showed to curb the growth of cancer cells including that of colon, pancreatic, lung, prostate, breast and leukemia.

Source: The health site


Sleepless teens likelier to get obese

A new study has demonstrated that teenagers who get less than six hours of sleep a night might be at risk of being obese as compared to their peers who sleep more than eight hours.

Sleepless teens likelier to get obese

Researchers at the Mailman School of Public Health at Columbia University and the University of North Carolina Gillings School of Public Health showed that teenagers had a high risk of being obese by age 21 and its was 20 percent higher among 16-year-olds who slept less than six hours.

Shakira F. Suglia, ScD, assistant professor of Epidemiology at the Mailman School, said that lack of sleep in teenage years could stack the deck against one for obesity later in life and if one becomes an obese adult, it was much harder to lose weight and keep it off and the longer one was obese, there was a greater risk for health problems like heart disease, diabetes, and cancer.

Suglia added that the message for parents was to make sure their teenagers got more than eight hours a night and a good night sleep did more than help them stay alert in school and it helped them grew into healthy adults.

The study is published in Journal of Pediatrics

Source: ANI news


Gambia on high alert for Ebola outbreak

Gambia’s ministry of health and social welfare said on Thursday that it is on high alert for a possible Ebola outbreak in the country and are taking preventive measures to tackle the disease.

Gambia, Ebola outbreak, Ebola alert, WHO

Modou Njai, director of health promotion and education at the ministry, said that so far there has been no confirmed case of the Ebola virus disease in Gambia, Xinhua reported.
“Currently there are public health officials stationed at all the border entry points, including at the airport and seaport and we are also increasing our surveillance teams countrywide to ensure that those going in and out are properly checked for Ebola virus,” Njai said.

According to Njia, 210 technical advisory committee members, 350 Red Cross volunteers, 75 local government authorities, 75 cluster monitors, 25 health journalists have been sensitised, including 36 representatives of youth groups who has been sent to various settlements in the country to sensitise people about the disease.

The preventive measures taken by the Gambia’s public health officials include reading passengers’ temperature and asking about their travel history. The public health officials are also in touch with regional health management teams posted in various regions, Njia added.

Gambia’s regional management teams coordinate and supervise surveillance teams posted to various locations in the country.

According to the World Health Organisation, the death toll due to the Ebola virus continues to rise in West Africa and currently stands at 1,350.

Source: IBN Live


14 lakh children do not live beyond the age of five: Dr Harsh Vardhan

Union Health Minister Dr Harsh Vardhan on Tuesday said, “It is a national shame that 14 lakh children do not live beyond the age of five. To change this reality the government needs the collective energy of the people, and should not rely on the government machinery.”

Union Health Minister Harsh Vardhan addresses press at Patna Airport on June 20, 2014. (Photo: IANS)

Speaking here at the launch of a music video, ‘Phool Khil Jayenge’ (The flower will bloom), on the subject of immunization, Dr Harsh Vardhan said, “Let’s make a pledge here to become ‘health sainiks’ and each of us would strive to inspire other ordinary people to become health volunteers to work for a healthy nation.”

In 1994, Dr Harsh Vardhan, in his capacity of Delhi’s Health Minister, had motivated hundreds of school children to become “polio sainiks” with the task of seeking out families with small children who needed polio immunization. It was their commitment and sincerity which resulted in the success of the first pulse polio day in Indian history –October 2, 1994.

“Today we are poised to replicate India’s success with polio eradication which was brought about by the unrequited and unpaid labour of thousands of people. We need more such heroes and heroines to make Universal Immunization in India a success,” the health minister said.

The music video, which emphasises the importance of providing immunity from disease to a child through timely inoculation, was made by Global Health Strategies in collaboration with the Ministry of Health and Family Welfare. The lyrics have been penned by Javed Akhtar, and the video features Vidya Balan and Farhan Akhtar. The music is by Lalit Pandit and the song is sung by Sonu Nigam.

Source: India medical Times


Nickel Allergies on Rise as Devices Meet Skin

As wearable devices become more popular, some doctors and consumers have expressed concerns about a lack of regulatory oversight to monitor the frequency of skin allergies and other reactions to certain metals or plastics used in the products.

Nickel Allergies on Rise as Devices Meet Skin

Nickel, one of the most common allergens in the United States, can be found in things like hand-held devices and jewelry. But unlike Europe, the United States has no restrictions on its widespread use in consumer products. That worries some doctors who say that the growing use of mobile and hand-held devices combined with a lack of regulatory oversight could lead to a spike in allergic reactions.

“I am absolutely concerned about it,” said Stephen P. Stone, the director of clinical research in dermatology at the Southern Illinois University School of Medicine and the former president of the American Academy of Dermatology.

The Centers for Disease Control and Prevention estimates that 10 to 20 percent of the population is allergic to nickel. The reactions can be unpleasant, but not fatal. Typically they include blistering, redness and dry skin.

In February, Fitbit, the maker of a popular brand of devices that measure physical activity, had to recall more than a million of its wristbands after receiving complaints about adverse skin reactions. In a statement on its website, the company said that users were most likely suffering from allergic contact dermatitis, a red and itchy rash, caused by either the adhesive or the nickel content.

That frustrated some users, especially those who had not previously suffered from a nickel allergy. Fitbit is facing legal action from consumers who want more information about the Fitbit Force, the line of products the company recalled.

“One of the things that’s really frustrating is that Fitbit will not say what caused the reaction,” said Alexandra Schweitzer, a health insurance executive from Massachusetts who said she developed what looked like an infected bug bite from her Force last year. Several years ago, dermatologists began seeing allergic reactions to cellphones, but some say the scope of the problem has since expanded.

In 2011, Walt Disney Parks and Resorts recalled about 1,200 children’s watches because of nickel in the watch’s back, according to the Consumer Product Safety Commission, the independent government agency in charge of recalls. A recent article in The Journal of Pediatrics pointed to a rise in nickel allergies among children and cited an 11-year-old boy who most likely had an allergic reaction to his iPad.

“With the increasing prevalence of nickel allergy in the pediatric population, it is important for clinicians to continue to consider metallic-appearing electronics and personal effects as potential sources of nickel exposure,” the article stated.

Nickel exposure from children’s toys in the United States poses a unique problem, because researchers say that frequent exposure to nickel can create sensitivity.

“I think nickel is still a really big issue in the United States,” said Bruce A. Brod, a clinical professor of dermatology at the University of Pennsylvania’s medical school. “Now we’re seeing some cases from iPads and laptop computers and some of the video games where there are metal pods.”

In an email, Chris Gaither, a spokesman for Apple, said that reactions described in the Pediatrics article were “extremely rare,” and that the company voluntarily adhered to international nickel guidelines.

“Apple products are made from the highest-quality materials and meet the same strict standards set for jewelry by both the U.S. Consumer Safety Product Commission and their counterparts in Europe. We rigorously test our products to make sure they are safe for all our customers,” he said.

When a recall is fast-tracked, as with the Force, the Consumer Product Safety Commission rarely performs its own testing. That leaves consumers at the mercy of the company to disclose the source of a problem.

“One of the scary things about a situation like this is that it induces a near state of panic when consumers have an adverse reaction and fear the worse,” said Joseph J. Siprut, a lawyer who filed a class-action complaint against Fitbit in March. The company said it did not believe that the lawsuit had merit.

The product safety agency has already received similar complaints for another Fitbit wristband, the Fitbit Flex, according to the safety agency’s online database.

“The company is constantly evaluating its products and working to improve its next-generation products,” James Park, the chief executive of Fitbit said in a statement. “As with any jewelry or wearable device, prolonged contact may contribute to skin irritation or allergies in a few users. Guidelines for product safety and hygiene are available on the website and we encourage users to follow these for maximum enjoyment of their Fitbit products.”

A spokesman for the consumer agency, Scott Wolfson, said it had the “power to take action” against “harmful metals or chemicals upon receiving information that there is a risk of exposure to consumers.”

Not all products that contain nickel pose a threat. How much nickel is in a product affects how much nickel seeps out of it, and Europe has guidelines that companies must follow. “The European directive has limited the use of nickel, but in the United States we haven’t, and it results in suffering and health care expenditure,” Dr. Brod said.

Source: New York Times